CUE · Cue Biopharma, Inc.

Substantial doubt about the company's ability to continue as a going concern.

“Our recurring losses from operations raise substantial doubt regarding our ability to continue as a going concern. Company management has obtained and continues to pursue additional financing and cost-management initiatives to support future operations, however such funding may not be available on acceptable terms or at all.”